Intra-Cellular Therapies Inc (NASDAQ:ITCI)

30.11
Delayed Data
As of Apr 19
 -1.09 / -3.49%
Today’s Change
16.14
Today|||52-Week Range
40.01
-5.31%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close31.22
Today’s open31.22
Day’s range29.59 - 31.50
Volume414,017
Average volume (3 months)632,454
Market cap$2.5B
Data as of 3:59pm ET, 04/19/2021

Growth & Valuation

Earnings growth (last year)-20.52%
Earnings growth (this year)+2.48%
Earnings growth (next 5 years)+2.50%
Revenue growth (last year)+37,537.11%
P/E ratioNM
Price/Sales98.08
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-4.23-2.82%
----
VCELVericel Corp-3.85-6.57%
GBTGlobal Blood Therape...-0.01-0.02%
Data as of 4:00pm ET, 04/19/2021

Financials

Next reporting dateMay 12, 2021
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$22.8M
Annual profit (last year)-$227.0M
Net profit margin-995.07%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts